Agraflora Organics International Inc OTCMKTS: PUFXF is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry.
On April 8th, 2019, the company annouced the execution of an asset sale agreement (“Agreement”) to transfer a suite of technology assets including the cannabis Smart Consumption System from Relay Medical Corp. to Glow LifeTech Ltd. (“Glow”).
The technology assets relate largely to the Smart Consumption System (“SCS”) currently being developed by Relay Medical to provide users and healthcare professionals with a medical grade, connected hardware/software product line to assist with effective management, storage, curation and consumption of cannabis related products. The storage product provides in-home secure, and environmentally controlled storage and guides dispensing and dosing for all cannabis delivery methods.
The system includes advanced management features for patient-caregiver interaction as well as an AI-driven engine, which can provide doctors and the pharmaceutical industry with valuable information on patient responses to cannabis products and to provide cannabis producers with market intelligence and the information to conduct post-market surveillance of their products.
“While there is a lot of focus and discussion around the growing recreational cannabis market there exists a clear gap in products, services, and technologies designed specifically for safe, consistent and responsible consumption of cannabis products. These concerns are especially clear within the healthcare sector where physicians and healthcare professionals are anxious and often resistant to prescribing cannabis treatment due to the largely inconsistent quality control and dosage issues so common in the marketplace.” said Lahav Gil, CEO & Director, Relay Medical Corp. “We believe that by providing consumers and prescribing physicians with the products to effectively identify, and confidently consume medicinal and recreational cannabis products, we can encourage responsible use and effectively ease consumer tension.”
“With the market place opening and the stigma around cannabis use fading, consumers are looking for guidance as to how to safely and confidently evaluate the potential benefits of cannabis products for both recreational and medical use,” said Derek Ivany, President & CEO, AgraFlora Organics International Inc. “The mandate of Glow LifeTech is to develop and support innovation in the cannabis sector to give consumers, producers and the industry at large, access to solutions to elevate industry standards and encourage responsible use. The Smart Consumption System is a great first step in addressing this initiative.”
On April 11th, 2019, AgraFlora Organics International made a major press release when announced corporate rebranding of investee company Empower Clinics Inc. (CSE: EPW) (Frankfurt 8EC) to better reflect their refocused and refreshed corporate profile and streamlined strategy to become a vertically integrated health and wellness company offering cannabidiol (CBD) based therapies, products and treatment options. As part of the rebranding, Empower will seek shareholder approval for a name change to “CBD Therapeutics Corp.” and it has changed its ticker symbol on the Canadian Securities Exchange to “CBDT”. A new corporate website will also follow.
“AgraFlora committed $1 million as a lead strategic investor in the recent financing by Empower Clinics Inc. as we continue to expand our footprint through strategic partnerships and co-operation in the global cannabis sector,” said Derek Ivany, President & CEO of AgraFlora Organics International Inc. “With the recent passing of the Farm Bill in the United States and the associated legalization of hemp and hemp based products, opportunities abound for the production and sale of a variety of CBD based products to the benefit of consumers’ health and wellness. Recent reports indicate the Farm Bill could create an industry valued in excess of US$20 billion by 2022. We look forward to building a powerful strategic partnership with Steve and his team at CBDT to gain a growing share of this burgeoning market.”
Empower has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients’ lives with products, technology and health systems. The name change will allow its patients, customers, shareholders, partners, team members and the investment community to have a simple and clear understanding of the Company’s focus – a brand that is passionate about CBD based therapies, products and treatment options.